Sava Infond d.o.o. Takes $43,000 Position in Enovix Co. (NASDAQ:ENVX)

Sava Infond d.o.o. acquired a new stake in shares of Enovix Co. (NASDAQ:ENVX) during the 4th quarter, HoldingsChannel reports. The institutional investor acquired 4,000 shares of the company’s stock, valued at approximately $43,000.

A number of other large investors also recently bought and sold shares of ENVX. Lpwm LLC bought a new position in shares of Enovix in the 4th quarter worth $549,000. Stifel Financial Corp grew its stake in Enovix by 6.2% in the third quarter. Stifel Financial Corp now owns 950,202 shares of the company’s stock valued at $8,875,000 after purchasing an additional 55,094 shares during the last quarter. Haven Private LLC bought a new position in Enovix in the fourth quarter worth about $454,000. Register Financial Advisors LLC lifted its position in shares of Enovix by 172.8% during the fourth quarter. Register Financial Advisors LLC now owns 174,850 shares of the company’s stock valued at $1,901,000 after buying an additional 110,750 shares during the last quarter. Finally, Amundi boosted its holdings in shares of Enovix by 360.8% in the 4th quarter. Amundi now owns 235,369 shares of the company’s stock valued at $2,558,000 after buying an additional 184,294 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.

Enovix Stock Performance

Shares of ENVX stock opened at $8.01 on Friday. The business has a fifty day moving average of $9.98 and a 200 day moving average of $10.03. Enovix Co. has a 1 year low of $5.70 and a 1 year high of $18.68. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of -5.52 and a beta of 1.93.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.01. The firm had revenue of $9.72 million during the quarter, compared to analysts’ expectations of $8.77 million. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. As a group, research analysts expect that Enovix Co. will post -1.01 earnings per share for the current year.

Analyst Ratings Changes

ENVX has been the subject of several recent analyst reports. Craig Hallum reduced their price objective on shares of Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price target on shares of Enovix in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Enovix presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.30.

Insider Buying and Selling at Enovix

In other news, CEO Rajendra K. Talluri sold 300,000 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $9.35, for a total value of $2,805,000.00. Following the completion of the transaction, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at $19,123,564.35. The trade was a 12.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 15.70% of the company’s stock.

Enovix Company Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.